Ethics Talk: Beyond the Drape in Surgeon-Anesthesiologist Relationships
In this episode of Ethics Talk, surgeon Dr Sara Scarlet and anesthesiologist Dr Patricia Doerr discuss their perspectives on surgeon-anesthesiologist relationships.
In this episode of Ethics Talk, surgeon Dr Sara Scarlet and anesthesiologist Dr Patricia Doerr discuss their perspectives on surgeon-anesthesiologist relationships.
What should clinicians do to change organizational cultures that negatively influence care they can deliver to patients? This month on Ethics Talk, Tara Montgomery and Dr Zackary Berger discuss how to identify and respond to health care organizational cultural influences…
Decision making in health care demands that we balance multiple considerations, like quality of life, statistics, and how different options could affect others. Dr Brian Zikmund-Fisher shares his own experience as a patient and explains how decision science can help…
Good epidemic responses require cross-disciplinary collaboration. Dr David Heymann talks about serving in an Ebola containment campaign and Dr Christy Rentmeester explains what clinicians should know about colonialism to promote health equity.
How should we prepare for rapid advancement of gene editing technology? This month on Ethics Talk, Dr Sean C. McConnell provides an introduction to gene editing and CRISPR technology and Scott J. Schweikart discusses what prudent governance requires.
In reconstructive transplantation, quality of life assessments incorporate many variables. Dr Katrina Bramstedt and Dr Ana Iltis discuss the development of QoL assessment tools to help patient-subjects considering reconstructive transplantation.
In this episode, transgender advocate and author Ryan Sallans discusses his experience accessing health care as a transman and offers a guide for caring well for anyone with a cervix.
Implantable brain-computer interface (BCI) and other devices with potential for both therapeutic purposes and human enhancement are being rapidly developed. The distinction between therapeutic and enhancement uses of these devices is not well defined. While the US Food and Drug…
Many devices in current use were marketed before the US Food and Drug Administration (FDA) began regulating devices in 1976. Thus, manufacturers of these devices were not required to demonstrate safety and effectiveness, which presents both clinical and ethical problem…
Recent research has highlighted device representatives’ roles in surgical cases. Additional review of cases based on actual events suggests that lack of training on the part of a surgeon and surgical team and lack of knowledge and training on the…
© 2026
American Board of Medical Specialties | Policies | Sitemap | Terms of Use | www.abms.org